AgeX Therapeutics, Inc. (AGE)

EBITDA

-$17.54M

TTM · Period ending: · USD

AGE logo

AGE EBITDA

Latest reported-$17.54M
AGE EBITDA (-$9.49M → -$17.54M)
High-resolution chart · PNG

AGE ebitda history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
73,000
194,000
-9,707,000
-7,055,000
-7,354,000
-8,812,000
-11,608,000
-10,710,000
-9,489,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.